|  ï»¿Drug name  | DrugBank ID  | Mechanism of action  | Experimental activity  | Measurement  |  Value  | Unit  | 
| ---- | --- | --- | --- | --- | --- | --- | 
|  Beclabuvir  | [DB12225](https://www.drugbank.ca/drugs/DB12225)  | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors  | Hepatitis C (HCV) remission/reduction, IN VITRO  | IC-50  | 3.00E-09  | M  | 
|  Remdesivir    | [DB14761](https://www.drugbank.ca/drugs/DB14761)  | RNA-Dependent RNA Polymerase Inhibitor    | Ebola virus disease remission/reduction, IN VITRO    | IC-50    | 1.00E-08  | M  | 
|  Valopicitabine  | [DB13920](https://www.drugbank.ca/drugs/DB13920)  | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors  | Hepatitis C (HCV) remission/reduction, IN VITRO  | IC-50  | 9.00E-08  | M  | 
|  Mericitabine  | [DB12045](https://www.drugbank.ca/drugs/DB12045)  | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors  | Hepatitis C (HCV) remission/reduction, IN VITRO  | IC-50  | 1.30E-07  | M  | 
|  Lumicitabine  | [DB14808](https://www.drugbank.ca/drugs/DB14808)  | RNA-Dependent RNA Polymerase (Respiratory Syncytial Virus) Inhibitors  | Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO  | IC-50  | 2.60E-07  | M  | 
|  Sofosbuvir  | [DB08934](https://www.drugbank.ca/drugs/DB08934)  | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors  | Infection, dengue virus remission/reduction, IN VITRO  | IC-90  | 4.00E-07  | M  | 
|  Adafosbuvir  | [DB14906](https://www.drugbank.ca/drugs/DB14906)  | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors  | Infection, dengue virus remission/reduction, IN VITRO  | IC-50  | 1.10E-06  | M  | 
